삼성서울병원

Ko En

Cardiology Chang, Sung A M.D

Expertise
Pulmonary hypertension, Ischemic heart disease, Diabetic cardiomyopathy, Pericardial disease, Multimodality cardiovascular imaging
Treament Schedule 04 月
DATE
MON
01
TUE
02
WEB
03
THU
04
FRI
05
SAT
06
SUN
07
MON
08
TUE
09
WEB
10
THU
11
FRI
12
SAT
13
SUN
14
MON
15
TUE
16
WEB
17
THU
18
FRI
19
SAT
20
SUN
21
MON
22
TUE
23
WEB
24
THU
25
FRI
26
SAT
27
SUN
28
MON
29
TUE
30
AM
PM
Treament Schedule 05 月
DATE
WEB
01
THU
02
FRI
03
SAT
04
SUN
05
MON
06
TUE
07
WEB
08
THU
09
FRI
10
SAT
11
SUN
12
MON
13
TUE
14
WEB
15
THU
16
FRI
17
SAT
18
SUN
19
MON
20
TUE
21
WEB
22
THU
23
FRI
24
SAT
25
SUN
26
MON
27
TUE
28
WEB
29
THU
30
FRI
31
AM
PM

Medical Education

Seoul National University College of Medicine, Seoul, Korea (Mar.1995-Feb.1997; premedical course, Mar. 1997-Feb. 2001; medical school)

Post-Graduate Training

Fellowship   Division of Cardiology, Seoul National University Hospital, Seoul, Korea (Mar.2006-Feb.2009)
Residency   Internal Medicine, Seoul National University Hospital, Seoul, Korea (Mar.2002-Feb.2006)
Internship   Seoul National University Hospital, Seoul, Korea (Mar.2001-Feb.2002)

Professional Appointments

* Master of Medical Science, Post-graduate School, Seoul National University (Mar.2004-Feb.2006)
* PhD in Medical Science, Post-graduate School, Seoul National University (Mar. 2006-Feb. 2008)

Professional Memberships

*License and Board :
Feb 2001 Korean License of M.D.
Feb 2006 Korean Board of Internal Medicine
Aug 2008 Korean Board of Cardiology
* Society Membership:
Mar 2001 - present : Active Member of Korean Medical Association
Mar 2006 - present : Active Member of Korean Society of Internal Medicine
Oct 2006-Present : Active Member of Korean Society of Circulation
Mar 2008-Present : Active Member of Korean Society of Echocardiography

Selected Publications

  • J THORAC DIS 2021 10.21037/jtd-20-3296 Optimal aerobic exercise intensity and its influence on the effectiveness of exercise therapy in patients with pulmonary arterial hypertension: a systematic review Seo1, YG; Oh, S; Park, WH; Jang, M; Kim, HY; Chang, SA; Park, IK; Sung, J
    View PubMed
  • LANCET RESPIR MED 2021 10.1016/S2213-2600(20)30532-4 Switching to riociguat versus maintenance therapy with phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension (REPLACE): a multicentre, open-label, randomised controlled trial Hoeper1, MM; Al-Hiti, H; Benza, RL; Chang, SA; Corris, PA; Gibbs, JSR; Grunig, E; Jansa, P; Klinger, JR; Langleben, D; McLaughlin, VV; Meyer, GMB; Ota-Arakaki, J; Peacock, AJ; Pulido, T; Rosenkranz, S; Vizza, CD; Vonk-Noordegraaf, A; White, RJ; Chang, M; Kleinjung, F; Meier, C; Paraschin, K; Ghofrani, HA; Simonneau, G
    View PubMed
  • J AM HEART ASSOC 2021 10.1161/JAHA.120.019856 Preoperative Right Ventricular Free-Wall Longitudinal Strain as a Prognosticator in Isolated Surgery for Severe Functional Tricuspid Regurgitation Kim1, M; Lee, HJ; Park, JB; Kim, J; Lee, SP; Kim, YJ; Chang, SA; Kim, HK
    View PubMed
  • KOREAN J RADIOL 2021 10.3348/kjr.2020.0082 The Extent of Late Gadolinium Enhancement Can Predict Adverse Cardiac Outcomes in Patients with Non-Ischemic Cardiomyopathy with Reduced Left Ventricular Ejection Fraction: A Prospective Observational Study Kim1, EK; Lee, GY; Jang, SY; Chang, SA; Kim, SM; Park, SJ; Choi, JO; Park, SW; Choe, YH; Lee, SC; Oh, JK
    View PubMed
  • J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e43 Impact of Atrial Fibrillation on Survival in Adults with Congenital Heart Disease: a Retrospective Population-based Study Jang1, SY; Huh, J; Kim, EK; Chang, SA; Song, JY; Kang, IS; Park, SW
    View PubMed